Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
In June of 2015, the Nassau Inn of Princeton, New Jersey played host to a conference focusing on the adoption and execution of mobile strategies within pharmaceutical companies.…
Each week The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
With a multitude of glucose meters on the market, it can sometimes be difficult for endocrinologists to maintain the inventory of software and cables necessary to access all…
CardioMEMS is a cardiac monitoring system from St. Jude Medical that has been proven to reduce heart failure hospital admissions by NYHA Class III patients.
Researchers have developed a way to communicate with human neurons through biochemical interactions, taking neurological medicine beyond the current limits of electrical impulse communication.
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Administering two types of immunotherapy drugs concurrently has paused or reversed malignant tumor growth in almost sixty percent of patients participating in a UK clinical trial.
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
